Copyright ©ERS Journals Ltd 2006 EUUSA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer1 Dept of Pathology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands, 2 Dept of Pathology, Aberdeen University School of Medicine, Aberdeen Royal Infirmary, Aberdeen, UK, 3 Dept of Pathology, INSERM U578, Grenoble, France, 4 Dept of Human Pathology and Oncology, University of Florence, Florence, Italy, 6 Dept of Pathology, KAS Herlev, div. Gentofte, Hellerup, Denmark., 5 Dept of Pathology, University of Colorado Health Science Centre, Aurora, CO 7 Dept of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, and 8 Fox Chase Cancer Centre, Philadelphia, PA, USA. CORRESPONDENCE: F. B. Thunnissen, Dept of Pathology, VU Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Fax: 31 204444586. E-mail: e.thunnissen{at}vumc.nl Keywords: Diagnosis, lung cancer, panel, pathology, screening
Received: March 29, 2006
Randomised controlled trials for lung cancer screening using high-resolution computed tomography are now underway. In order to allow effective future comparison of the different trials, as well as strengthening conclusions based upon the analysis of larger data sets, uniformity and consistency of pathology diagnosis are essential. The aim of the present study was to determine the effectiveness of the learning process in this difficult area of diagnostic pathology.
Eight pathologists received two CD-ROMs, each with digital images of 30 cases. After diagnosing the first series, selected background reading was provided. Kappa (
The readings of the first series showed a moderate agreement
In conclusion, this study demonstrates that screen-detected cases pose particular problems for pathologists and that a trained pathology panel serving randomised controlled trials is likely to lead to more consistent and accurate tissue diagnosis.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||